Executive leadership BioVid recently promoted Peggy Hirtle to Chief Executive, signaling potential strategic shifts and renewed focus on growth initiatives. This presents an opportunity to engage with C-suite about high-value market access and AI-driven research services aligned with new leadership priorities.

Market access focus Specialization in commercial market research and strategic market access consulting indicates demand for end-to-end support in payer negotiations, pricing strategy, and reimbursement pathways. Target health systems, biopharma, and biotech clients seeking to optimize market access can be strong potential buyers.

AI and behavioral science Combining behavioral insights with AI tools (TensorFlow, SciPy, pandas) suggests opportunities to upsell advanced analytics, customer segmentation, and predictive modeling services for launch planning, messaging optimization, and stakeholder mapping.

Revenue range Current revenue is in the mid to upper six figures to low seven figures range. This implies potential for scalable, modular service packages and retainer-based engagements with mid-sized life science clients seeking measurable ROI from market insights.

Tech-enabled delivery A tech stack including Tableau, TensorFlow, and Python data tooling indicates capability to deliver interactive dashboards and AI-driven insights for clients. Propose value through self-serve analytics pilots and ongoing executive dashboards to drive decision making.